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Abstract.  We report the identification and character- 
ization of myr 4  (myosin from rat), the first mam- 
malian myosin I that is not closely related to brush 
border myosin I. Myr 4 contains a myosin head (mo- 
tor) domain, a regulatory domain with light chain 
binding sites and a tail domain. Sequence analysis of 
myosin I head (motor) domains suggested that myr 4 
defines a novel subclass of myosin Fs. This subclass is 
clearly different from the vertebrate brush border myo- 
sin I subclass (which includes myr 1) and the myosin I 
subclass(es) identified from Acanthamoeba  castellanii 
and Dictyostelium discoideum.  In accordance with this 
notion, a detailed sequence analysis of all myosin I 
tail domains revealed that the myr 4 tail is unique, ex- 
cept for a newly identified myosin I tail homology 
motif detected in all myosin I tail sequences. 
The Ca2+-binding protein calmodulin was demon- 
strated to be associated with myr 4.  Calmodulin bind- 
ing activity of myr 4  was mapped by gel overlay as- 
says to the two consecutive light chain binding motifs 
(IQ motifs) present in the regulatory domain. These 
two binding sites differed in their Ca  2÷ requirements 
for optimal calmodulin binding. The NH2-terminal IQ 
motif bound calmodulin in the absence of free Ca  2+, 
whereas the COOH-terminal IQ motif bound calmodu- 
lin in the presence of free Ca  2+. A  further Ca  2+- 
dependent calmodulin binding site was mapped to 
amino acids 776-874  in the myr 4 tail domain. These 
results demonstrate a differential Ca  2+ sensitivity for 
calmodulin binding by IQ motifs, and they suggest that 
myr 4 activity might be regulated by Ca2+/calmodulin. 
Myr 4 was demonstrated to be expressed in many 
.cell lines and rat tissues with the highest level of ex- 
pression in adult brain tissue. Its expression was de- 
velopmentally regulated during rat brain ontogeny, ris- 
ing 2-3 wk postnatally, and being maximal in adult 
brain. Immunofluorescence localization demonstrated 
that myr 4 is expressed in subpopulations of neurons. 
In these neurons, prominent punctate staining was de- 
tected in cell bodies and apical dendrites. A punctate 
staining that did not obviously colocalize with the 
bulk of F-actin was also observed in C6 rat glioma 
cells. The observed punctate staining for myr 4  is 
reminiscent of a membranous localization. 
D 
RECTED movements along actin filaments are thought 
to be important for intraceUular trafficking and cell 
shape changes. The motor molecule myosin  converts 
chemical energy into directed mechanical force along actin 
filaments.  Myosin (conventional myosin or myosin 1I) has 
been demonstrated to function in muscle contraction, cyto- 
kinesis,  and capping of surface receptors (15, 33, 38, 49). 
However, it is difficult to envision one motor molecule  being 
responsible for all actin-dependent  motility phenomena. Re- 
cent evidence suggested that there exists a superfamily of 
myosin molecules (7, 26).  All members of the superfamily 
share a characteristic motor domain with ATP and F-actin 
binding  sites  that  defines  them as  myosins.  Further,  all 
known myosins contain variable numbers of light chains. In 
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addition,  they exhibit different tail domains that are postu- 
lated to specify the respective function(s)  of each myosin 
molecule (for review see references  6, 28, 50). Myosin I mol- 
ecules  (class  I  myosins)  were  first  identified  in  Acan- 
thamoeba castellanii and close relatives have been cloned 
from Dictyostelium discoideum (34-37, 44, 51, 59, 60). Un- 
til very recently, only a single myosin I from vertebrate tis- 
sue, known as brush border myosin  I, had been characterized 
and cloned (for review see reference  6). However, biochemi- 
cal data from various vertebrate tissues pointed to the pres- 
ence of a family of myosin I molecules (4, 12, 42). Our labo- 
ratory has reported the characterization and cloning of a 
ubiquitous myosin I from rat that is related to brush border 
myosin  I. This myosin  I molecule  exists in three splice forms, 
named myr 1 a-c (53). Partial  sequences of two additional 
vertebrate myosin I  molecules have  also been presented 
(39, 56). 
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so far have associated as light chains several molecules of the 
calcium-binding protein calmodulin (4, 46). The calmodulin 
molecules are thought to bind at the motor/taft domain junc- 
tion (24, 32). In this region, aU myosins contain one or more 
copies of an imperfect repeat of ~23 amino acids,  termed 
the IQ motif (6). It has been demonstrated for brush border 
myosin I and a myosin I isolated from adrenal giand that the 
actin-activated  ATPase activity is modulated by the second 
messenger calcium (4,  9,  14, 58).  Moreover,  elevation of 
free calcium ion concentrations  in vitro lead to the partial 
dissociation of calmodulin molecules from brush border my- 
osin I and to the inactivation  of its motor activity (9,  10). 
Therefore,  the analysis  of fight  chain/calmodulin  binding 
could provide insight  into the regulation  of motor activity 
and more generally into the molecular mechanisms  involved 
in regulating myosin function.  Alternatively, unconventional 
myosins may be responsible for proper subcellular localiza- 
tion of calmodulin, as recently demonstrated for the Dro- 
sophila ninaC  protein (52). 
Several myosin I molecules have been localized to mem- 
branes (2, 3, 23, 46, 62), suggesting a role for myosin I mole- 
cules in membrane trhffic. Acanthamoeba myosin IA, IB, 
and IC were localized differentially  to specific membrane 
domains.  Myosin IA was found in the cell cortex, beneath 
phagocytotic cups, and in association with small cytoplasmic 
vesicles.  Myosin IB was associated with the plasma mem- 
brane,  large vacuole membranes,  and phagocytotic mem- 
branes (2).  Myosin IC localized to the plasma membrane, 
large vacuole membranes, and the contractile vacuole mem- 
brane (3). All three myosin I's were also detected to varying 
degrees in the cytoplasm, suggesting the possibility that the 
association with membranes is under physiological  regula- 
tion.  In Dictyostelium, myosin I has been localized at the 
leading  edge of migrating  cells and in phagocytotic cups 
(22).  Vertebrate  brush border myosin I forms lateral links 
between the plasma membrane and the actin bundle of the 
microvilli  (11, 46), and may also be associated with small 
vesicles (18, 20). A mammalian  myosin I has been localized 
to filopodia,  lumellipodia,  and fine punctae in the perinu- 
clear region (61). In accordance with the in situ localization 
at membranes,  in vitro biochemical experiments  demon- 
strated  a high affinity interaction  of Acanthamoeba myosin 
rs and brush border myosin I with anionic phospholipids and 
membrane preparations (1, 2, 29, 47). 
To explore a potential involvement of myosin I molecules 
in membrane trafficking in nervous tissue, we attempted to 
identify myosin I molecules expressed in this tissue.  In this 
report, we describe the identification and characterization  of 
a novel mammalian myosin I called myr 4. It was identified 
with a previously described antibody raised against a con- 
served sequenced in myosin I molecules (53).  Cloning  and 
sequencing  of myr 4 revealed that it does not belong to the 
brush border myosin I subclass, but it defines a new subclass 
of myosin I molecules.  Myr 4  was demonstrated to bind 
calmodulin,  and two calmodulin-binding  sequence motifs 
with differential  Ca2+-sensitivity were identified.  Analysis 
of all known myosin I tail sequences led to the identification 
of a conserved myosin I tail homology motif. Myr 4 was 
found to be expressed in many cell lines and tissues.  Its ex- 
pression in the brain was developmentally regulated.  Local- 
ization studies suggested an organellar localization ofmyr 4. 
Materials and Methods 
Purification of  myr 4 
60-65 freshly excised rat brains were homogenized in 600 ml of 0.32 M 
sucrose, 5 mM Hepes, pH 7.4, using a motor driven Dounce homogenizer. 
The homogenate was centrifuged in a Sorvall SS34 rotor (Du Pont-Nemours, 
Bad Homburg,  Germany) at 16000 rpm for 30 min. The pellets were resus- 
pended in H20 to a volume of 400 ml and rehomogenized  in a tight-fitting 
Dounce homogenizer.  ARer centrifugation at 50,000  rpm for I h (Ti 60; 
Beckman Instruments, Inc., Fullerton, CA), the obtained pellets wore re- 
suspended in 0.2 M NaCI,  15 mM CHAPS, 20 mM Hapns, pH 7.4, 1 mM 
EDTA, and 0.1 mM EGTA.  The suspension was centrifuged as above and 
the pellets wore extracted two more times with the identical buffer. The final 
pellets wore resuspended in either 0.2 M NaCI,  15 mM CHAPS, 20 mM 
Hepes,  pH 7.4,  10 mM MgC12, or 0.4 M NaC1, 20 mM Hepes, pH 7.4, 
and 20 mM MgC12 (the latter buffer yielded a better extraction efficiency 
for myr 4, but caused a higher level of contamination with conventional 
brain myosin). To this suspension we added 0.I M ATP, pH 7.2, to a final 
concentration of 5 raM. After centrifogation,  the pellets wore reextracted. 
To the pooled supernatants we added a saturated solution of ammonium sul- 
fate (pH 7.2, 0.1 mM EGTA) to a final concentration of 55%. The suspen- 
sion was centrifuged in a GSA rotor (Sorvall) at 13,000 rpm for 30 min. 
The pellets wore re.suspended in and dialyzed  asainst a buffer of 50 mM 
NaCI, 20 mM Hepes, pH 7.4, 1 mM MgCI2, 1 mM dithiothreitol, 0.1 mM 
EGTA,  and 2 mM NAN3. During dialysis,  a precipitate formed.  The pre- 
cipitate was collected by centrifugation for 1 h in a Ti 60 rotor at 50,000 
rpm. The pellets were re,  suspended in dialysis buffer supplemented with 20 
mM MgC12, and myr 4 was extracted twice with ATP (final concentration 
=  10 raM). The supernatants wore loaded onto a column (FPLC Mono Q; 
Pharmacia, Preiburg, Germany) preeqnilibrated in 20 mM Hepes, pH 7.4, 
20 mM NaC1, 2 mM MgCI2, 0.2 mM EDTA, and 0.5 mM 2-mercaptoetha- 
nol. The Mono Q column was developed with a linear salt gradient and myr 
4 eluted at an approximate ionic  strength of 200-250 mM NaCI, just ahead 
of the bulk of conventional myosin. Fractions containing myr 4 were pooled, 
diluted 1:1 with H20~ and loaded onto a 5-ml ADP-agarose colunm (GIBCO 
BRL, ~thersburg, MD), preequilibrated in a buffer of 50 mM KCI, 20ram 
Hepes, pH 7.4, and 1 mM dithiothndtol.  The column was developed with a 
linear salt gradient (0.05-1 M KC1) in a total volume of 40 ml, followed by 
a wash with buffer containing 0.45 M NaCI, 20 mM Hepes, pH 7.4, 50 mM 
KC1, and 1 mM dithiothreitol.  Finally, myr 4 was eluted with the same buffer 
supplemented with 20 mM  MgCI2 and I0 mM  ATP. 
When the initial extraction  from the tissue  was performed  in high salt 
buffer (0.4 M NaC1), conventional myosin was a prominent covtamirmnt of 
the ADP-agarose  eluate.  Conventional  myosin  and myr  4 were separated  by 
gel  filtration  chromatography  on  a Superose  6 column (Phanmcia)  run  in  a 
buffer  of  0.5  M  NaCI, 20  mM Hepes,  pH 7.4,  I0  mM MgCh, 5 mM ATP, 
0.I mM  EGTA, and 2 mM  NAN3. 
Amino Acid Sequence Determination 
Purified myr 4 was separated by SDS-PAGE, stained with Coomassie blue, 
and excised from the gel.  It was reelectrophomsed  on a  10-20~ gradient 
SDS-pelyacrylamide  gel in the presence of Staphy/ococcus aureus V8 pro- 
tease (6/,g) as desoribed by Cleveland et al. (8). Digested peptides were elec- 
trophoretically  transferred  to a  polyvinyldifluoride  immobilon membrane 
(Mimpore Corp.,  ~tford, MA), stained,  and sequenced  as described  by 
Mamudaira (45)  using  a  gas  phase sequencer  (Applied  Biosystems,  Inc.,  Fos- 
ter City,  CA). 
Actin Binding 
Actin was purified from rabbit skeletal muscle as described by Pardee and 
Spudich (48) and stored as G-actin at -70°C. Actin (1 mg/ml) was polymer- 
ized in a buffer of 100 mM KCI, 2 mM MgCI2, 20 mM Hepes, pH 7.4, 0.5 
mM 2-mercaptoethanol, and 2  mM NAN3. F-actin-bindiog assays  wore 
performed in total volumes of 50 or 100/d containing 5/~M actin. Fractions 
eluting from the Mono Q column (see above) enriched in myr 4 were added 
to the assay mixture.  The assay buffer consisted of 20 mM Hepes, pH 7.4, 
2 mM MgCI2, 0.5 mM 2-mercaptoethanol, 0.4 mM NAN3, 20 mM KCI, 
and '~175 mM NaCI contributed by the myr 4 column fractions.  Samples 
were incubated for 20-30 rain at 4°C. ATP (final concentration =  2 raM) 
was added from a concentrated stock solution (100 raM) 5 min before cen- 
trifugation. Supernatants and pellets wore obtained after centrifugetion in 
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Fullerton, CA) at 75,000 rpm for 20 min, and were analyzed for myr 4 con- 
tent by irnmunoblotting. 
Isolation, Sequencing, and Analysis of myr 4 cDNAs 
Degenerate sense and antisense primers were deduced from the determined 
peptide sequences FHGVKNM (primer 1) and KDKYMNV (primer 2), and 
EcoRI restriction  sites  were  added  at  their  Y-ends.  A cDNA fragment  was 
amplified  by the polymerase chain  reaction  using  these  primers (10 ~M 
primer I,  3 tiM primer  2) and  first-strand  eDNA from  rat  brain  poly  (A)  + 
RNA (0.2  ~tg)  reverse  transcribed  with  a cDNA cycle  kit  (Invitrogen,  San 
Diego,  CA). 30  cycles  (I  min at  94°C, 1  rain  at  50°C, and 3 rain  at  72°C) 
were  run for  amplification.  The amplified  PCR product  was purified  from 
low-melt  agarose,  digested  with EcoRI, and subcloned  in  pBluescript  KS 
vector  (Stratagene,  La  Jolla,  CA). The subeloned  PCR fragment (nucleo- 
tides  [nt]  1  2443-2775) was labeled  with [a,32p]dCTP  (Amersham Corp., 
Arlington  Heights,  IL) by a random primed labeling  method (Boehringer 
Mannheim, Mannheim, Germany).  V~th  this  probe,  2 × 106  recombinants 
of  an  adult  rat  brain  X-ZAP-II  eDNA library  (generous  gift  of  Dr.  C.  Garner, 
Zentrum  fiir  Molekulare  Neurobiologle, Hamburg,  Germany)  were 
screened,  and  two  independent  clones  (called  6 and  21a)  were  isolated.  Hy- 
bridization  and washing were performed according to standard procedures 
(54). The pBluescript plasmids were excised from the k-ZAP-H phages ac- 
cording to the in vivo excision protocol of the supplier (Stratagene).  The 
clones 6 and 21a were subjected to DNA sequencing.  Since clones 6 (nt 
256-3761) and 2la (nt 1741-3480) did not contain the entire coding region 
of rnyr 4, a rat bralnstem/spinal cord )~-ZAP-II library (Stratagene)  was 
screened with a fragment (nt 256-642) derived from clone 6. This screen 
yielded eight independent clones.  Clone 34b (nt 1-530) derived from this 
screen was completely sequenced. 
DNA Sequencing 
Nucleotide sequences were determined by the method of Sanger et al. (55) 
using double-stranded DNA templates and the Sequenase  version 2.0 kit 
(U.S.  Biochemical Corp.,  Cleveland, OH).  FOr sequencing,  a  series of 
nested deletions were carried out according to the method of Henikoff (30) 
with an Erase-a-Base kit (Promega Corp., Madison, WI). All sequences 
were determined from both strands of the cDNA. Nucleotide and amino 
acid sequences were analyzed with the PC-Gene soRware package  (intel- 
ligenetics,  Mountain  View, CA) and  the  University  of  Wisconsin Genetics 
Computer Group (reference  16, version  7.0)  software  package. 
Cloning and Expression of  Fusion Proteins 
Myr 4-specific primers with added recognition sequences of restriction en- 
donucleases were used to amplify defined myr 4 fi-agments by PCR. PCR 
reactions were run through 30 cycles (1 rain at  92°C,  1 rain at  600C, and 
1 rain  at 74°C).  PCR fragments were separated on I% agarose  gels and 
purified with glassmilk (Qia-Ex; Diagen, I-Iilden, Germany). The isolated 
fragments were cloned into pUC18 using the sure clone ligation kit (Phar- 
macia) and subcloned into the pIH-902 expression vector (New England 
Biolabs, Schwalbach, Germany). The three fragments encompassing amino 
acids 500-699, 500-721,  and 500-743 were cloned into the BamHI and 
HindIII cloning sites of pill-902. Fragments encompassing amino acids 
722-777,  743-777,  and 810-876 were cloned into the EcoRI and PstI clon- 
ing  sites,  whereas  the  fragments encoding  amino  acids  743-898  and 
810-898 were cloned into the EcoRI and XbaI cloning sites. The fragment 
encompassing amino acids 747-858 was cloned into the EcoRI site of the 
expression vector pMalcRI (New ~nSland Biolabs). The fusion protein en- 
coding amino acids 776-1006 was constructed by ligating  a PstI/HindHI 
fragment of clone 2la into the corresponding restriction sites of pIH-902. 
Nested deletions starting from the 3'-end of the subeloned 21a cDNA were 
generated to yield eight successively  more truncated fusion proteins. Their 
3"sequences were determined by DNA sequencing. 
The plasmids coding for the various fusion pmteius were transformed 
into Escherichia coli, DHSa strain and cells were grown in Terrific Broth 
medium to an ODe0 -- 0.4. Expression of fusion proteins was induced by 
addition of isopropyl-~-v-thiogelactopyranosid  (0.3 mM). After 3 h of incu- 
bation, cells were harvested and dissolved in SDS gel sample buffer and 
boiled for 3-5 rain. 
1. Abbreviation  used in this paper:  nt, nucleotides. 
Calmodulin-binding Assay 
Approximately equal amounts of fusion proteins were separated by 10% 
SOS-PAGE.  Gels were overlayed  with t2SI-calmodulln (purchased from 
New England Nuclear,  Dreieich, Germany) in the presence or absence of 
free calcium (0.1 mM CaCI2 and 3 mM EGTA, respectively)  as described 
by Slaughter and Means (57).  The dried gels were  exposed  to Kodak 
X-Omat AR film at -70°C with an intensifying screen (Cronex Quanta HI; 
Du Pont, W'flmington, DE). 
Generation of myr 4-specific  Antibodies 
The synthetic  peptide GTFVPVANELKRKDKYMNC  (amino acids 839- 
856) was coupled to keyhole limpet hemocyanin with m-maleimidobenzoyl 
suifosuccinimide  ester (Pierce Chemical Co., Rockford,  IL) and injected 
into rabbits (27). Antisera (Tfi 12 and Tfi 13) were affinity purified over the 
myr 4 fusion protein MBP/21a tail (amino acids 776-1006) coupled to resin 
(AminoLink; Pierce Chemical Co.). The fusion protein MBP/21a taft was 
expressed in E. coli and purified from washed inclusion bodies by prepara- 
tive SOS-PAGE. The MBP/21a tail fusion protein band was made visible 
by copper staining (41), cut out of the gel, destained, frozen in dry ice, and 
minced in a mortar. Protein was °luted from the minced gel (1% SOS, 0.1 
mM EGTA,  and 50 mM EDTA),  concentrated (Centriprep-30; Amicon, 
Beverly, MA), and finally pelleted with an equal volume of cold acetone 
in a dry ice/ethanol  bath and washed once with 50% acetone. The dried pro- 
tein pellet was resuspended in 5 M m'e~, 0.1 M NaI-ICOs, pH 8, and cou- 
pled to AminoLink resin (Pierce Chemical Co.) according to the instruc- 
tious of the manufacturer.  Antibodies were affinity purified as deseribed 
(53). Antibody TO 14 was raised against fusion protein QE8/21a, which was 
constructed by cloning cDNA clone myr 4/21a (amino acids 513-1006) over 
BamI-II and HindiII sites into the His-tag pQE8 vector (Qiagen, Chats- 
worth, CA). The bacterial fusion protein was affinity purified under dena- 
turing conditions over Ni-NTA resin (Qlagen), as described by the manufac- 
turer.  Antisera TO 14 was  affinity purified on the MBP/21a  tail resin as 
described above. 
Cell Culture 
Madin-Darby canine kidney cells and HepG2 cells (obtained from Dr. Iris 
Geffen, Biozentrurn, Basel, Switzerland), as well as NMU cells (American 
Type Culture Collection [ATCC],  Rockville,  MD), were grown in MEM 
medium, 10% fetal calf serum. C6 cells (obtained from Dr. B. Hamprecht, 
Tfibingen, Germany), Neuro-2A (Dr. Elisabeth Pollerberg,  Physiologische 
Chemic,  Max-Planck Iustitut,  Tiibingen)  and COS  cells (Dr.  Christine 
Dreyer,  Max-Planck Institut, Tfibingen) were grown in DME,  10% fetal 
calf serum. NIH 31"3 cells (Dr. Iris Geffen) were cultured in DME and 7.5 % 
fetal calf serum; AtT20 cells (ATCC) in Ham's FI0 with 10% horse serum 
and 2.5% fetal calf serum; PC12 cells (ATCC) in RPMI 1640, 10% horse 
serum, and 5% fetal calf serum; IC-21  cells (ATCC) in RPMI 1640 and 
10% fetal calf serum; P388D~ cells (ATCC)in RPMI 1640 and 15% fetal 
calf serum. All cells were grown at 37°C  in a humidified 10% CO2 at- 
mosphere. 
Immunofluorescence 
For indirect immunofluorescence  labeling, cells were washed in PBS and 
fixed in either 3 or 4 % paraformaldehyde  in PBS.  After quenching with 
0.I M glycine/PBS,  cells were permeabilized for I0 rain in 0.05% sapunin. 
Primary and secondary antibodies were appropriately diluted in 10% nor- 
mal goat serum/PBS.  Secondary goat anti-rabbit antibodies coupled to 
rhodamine or Cy3  were purchased from Dianova  (Hamburg, Germany), 
fluorescein-coupled  phallacidin was from Molecular Probes (Eugene, OR), 
respectively. To remove unbound antibodies, cells were rinsed several times 
with PBS and then mounted (15% moviol and 30% glycerol  dissolved in 
PBS, pH 8). 
Immunostalning of frozen rat brain sections was performed as follows: 
rats  were anaesthetized  with 7% chloralhydrate,  transcardlally  perfused 
with  PBS, followed  by fixative  consisting  of  4  % paraformaldehyde  in  PBS. 
The  brain  was  excised,  equilibrated  in  30% sucrose/PBS,  molded  in  Tissue 
Tek (Miles  Inc.,  Elkhart,  IN),  and frozen  in  liquid  nitrogen.  Cryosections 
(10/trn)  cut  at  -20°C in  a  FrigoCut  (model  2700; Reichert  und  ]ung,  Nuss- 
loch/Heidelberg,  Germany)  were  adsorbed  onto  glass  slides  pretreated  with 
I% gelatin,  0.05% (Nl-h)CrO4.  Sections  were incubated  overnight  at  4°C 
with affinity-purified  myr 4 antibodies  appropriately  diluted  in  PBS, 10% 
goat  serum, 0.5% Triton  X-100 followed  by three  washes  with  PBS. After 
incubation  with  goat  anti-rabbit  Cy3 (1:500)  for  I-2  h at  room  temperature 
and three  washes with PBS, sections  were mounted as described  above. 
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Identification and Characterization  of  myr 4 
We used our previously described myosin I consensus anti- 
body (53)  to probe adult rat brain tissue for novel myosin 
I(s). In this tissue, the consensus antibody reacted strongly 
with a protein of 110 kD (Fig. 1A). In addition, it also recog- 
nized a faint band at 130 kD, previously identified as myr la 
(53), and ~vo proteins of 95 and 85 kD, respectively. The 
110-kD protein was termed myr 4 (myosin from rat) and fur- 
ther characterized. 
A characteristic of myosin molecules is their nucleotide- 
dependent binding to F-actin. To test myr 4 for nucleotide- 
dependent F-actin binding activity, we partially purified myr 
4. Myr 4 was extracted with MgATP and high ionic strength 
buffer, precipitated by ammonium sulfate, dialyzed against 
a low salt buffer to form an acto-myosin pellet,  extracted 
with MgATP, and chromatographed over a MonoQ column. 
Fractions enriched in myr 4 protein were tested for F-actin 
binding ofmyr  4. As shown in Fig. 1 c, myr 4 did cosediment 
with F-actin in the absence of  MgATP, but not in the presence 
of MgATP, demonstrating ATP-dependent binding. 
Primary Structure Determination of  myr 4 
To obtain peptide sequence information, we attempted to pu- 
rify the protein (see Materials and Methods) (Fig. 1 B). The 
major contaminant still present in the purified preparation 
was actin.  This preparation also contained a  protein that 
comigrated on SDS-PAGE with calmodulin. The myr 4 pro- 
tein band was cut out of SDS gels and reelectrophoresed in 
Figure 1. (,4) Identification  of  myr 4. Immunoblot of adult rat fore- 
brain homogenate with antibody G-371 directed against a myosin 
I consensus  peptide. The myr  4 band and molecular mass standards 
(in kilodultons) are indicated. (B) Purification of myr 4. Partially 
purified myr 4 was separated on 7.5-15% gradient SDS-PAGE and 
stained by Coomassie blue. Purification was monitored by immu- 
noblotting with antibody G-371. Molecular mass standards (in kD) 
are indicated. Myr 4 is marked by an arrowhead, and actin, the ma- 
jor contaminant  in the preparation, is denoted by an asterisk. A pro- 
tein band comigrating  with calmodulin  is indicated  by an arrow. (C) 
ATP-dependent  binding of myr 4 to F-actin. Partially purified myr 
4 (Mono Q fractions, see Materials and Methods) was incubated 
in the absence (-) or presence (+) of actin (5/~M) and ATP (2 
mM), respectively.  The F-actin bincling  was assayed  by cosedimen- 
tation with F-actin. Supernatants (s) and pellets (p) were analyzed 
for their myr  4 content by immunoblotting  with the (3-371 antibody. 
Molecular mass standards (in kilodaltons) are indicated on the left. 
the presence of S. aureus V8 protease. Five of the obtained 
myr 4 fragments were subjected to peptide sequencing (un- 
derlined in Fig. 2). Degenerate oligo nucleotide  primers cor- 
responding to two myr 4 peptide sequences determined by 
direct protein  sequencing were used to amplify a  cDNA 
fragment by PCR. A rat brain cDNA library was screened 
with the amplified cDNA fragment and the cDNA clones 6 
and 21a were isolated. Since these clones did not contain the 
entire coding region of  myr 4, a brainstem/spinal cord cDNA 
library was screened with a 5' fragment of clone 6. Several 
clones were isolated, and clone 34b was further analyzed. 
The myr 4 cDNA exhibited an open reading frame of 3,018 
hp coding for a protein of 1,006 amino acids (Fig. 2). The 
open reading frame of myr 4  started with an initiation se- 
quence conforming to the consensus initiation sequence de- 
scribed by Kozak (40). The calculated molecular mass from 
the deduced amino acid sequence of 116,190 D was in good 
agreement with the apparent molecular mass of 110 kD de- 
termined by SDS-PAGE.  The five peptide sequences ob- 
tained by direct amino acid sequencing were found to match 
exactly with the deduced amino acid sequence (Fig. 2). Fur- 
thermore, the peptide sequence recognized by the consensus 
antibody G-371  was  identified at  amino  acids  612--630. 
These data provided unequivocal evidence that the cDNA 
clones were coding for myr 4. 
Sequence Analysis and Structural Organization 
of  myr 4 
Sequence analysis of the deduced amino acid sequence re- 
vealed that myr 4 exhibits an amino-terminal head (motor) 
domain (amino acids  1--699), a putative light chain bind- 
ing domain (amino acids 700--762), and a carboxy-terminal 
tail domain (amino acids 763-1006).  The motor domain of 
myr 4 was homologous to the motor domains of other myo- 
sins. It contained the characteristic sequence motifs such as 
ATP-binding site, actin binding site, and conserved sequence 
motifs of as yet unidentified functions. Based on its motor 
domain, sequence myr 4 could be classified as a myosin I. 
However, it could not be grouped with any of  the known myo- 
sin I subclasses (Fig. 3). The motor domain amino acid se- 
quence revealed an identity of 51.3 % to rat myr lc, 49.3 % 
to chicken brush border myosin I, and 48.7 % to bovine brush 
border  myosin I.  It exhibited 49.3%  identity to  D.  d/s- 
coideum myosin IA and 48.5% to D. discoideum myosin IE. 
Myr 4 was less similar to the other vertebrate myosin I's than 
they are to each other. Chicken brush border, bovine brush 
border, and myr 1 myosin l's exhibit 66-69% sequence iden- 
tity. Myr 4  may therefore represent the first member of a 
novel subclass of myosin l's because the myosin I molecules 
identified in A. casteUanii and D. discoideum are also more 
closely related to each other than to myr 4 (Fig. 3). This con- 
clusion is also supported by the identification of a myosin I 
from the phylogenetically  distant fruit fly Drosophila mela- 
nogaster, which groups together with myr 4 (Morgan, N. S., 
D. M. Skovronsky, S. Artavanis-Tsakonas,  and M. Moose- 
ker, personal communication) and by amino acid sequence 
analysis of the tail domain (see below). 
A recently published partial myosin I motor domain se- 
quence from rat origin, referred to as myosin Iq~ (56), was 
virtually identical to amino acids 145-571  in myr 4. The par- 
tial myosin I~ sequence differed from the myr 4 sequence in 
The Journal of Cell Biology, Volume 126,  1994  378 M  A  E  Q  E  S  L  E  G  K  12 
241  GACTTCGT GCTGATGGACACCGTCTC  CATGCCCGAGTTCATGGC  CAACCTTAGGCTCAGATTTC, AGAAAGGACGCATC TATACATTCATTGGC GAGGTG~TCGT TTCC  GTGAAC  CCATAC 
DFVLMDTVSMP  EFMANLRLRFEK  R  I  T  F  I  G  E  V  V  V  S  N  P  52 
361  AAGGTGCTGAACATCTATG~AGGGACACAATTOAGCAGTACAAAGGT  CGGGAGCT GTACGAGAGACCTCCTCATCT  CT  TCGCTATCTTGGACGCTG°TTACAAGGC  TATGAAGAGGCGA 
K  V  L  I  y  G  R  D  T  I  E  Q  Y  K  G  R  E  L  Y  E  R  P  R  L  F  A  I  L  D  A  A  Y  K  A  K  R  92 
481  TCAAAAGACACCTGTATTATGATATCA~GGGAAAGT  GGAGCT  GGTAAAACAGAGGCCAGTAAGTACATCATGCAGTATATCGCCGCCAT  CAC  CAACC  CCAGCCAGAGAGCAGAGATAGAA 
$  K  D  C  I  M  I  S  GE  S  GAGKTEAS  KY  I  M(~Y  A  A  I  T  N  P  S  Q  R  E  I  132 
601  AGAGTGAAGAATATGTTGCT  GAAGT  C^AAC  TGTGTTTTGGAAGCTT  TT  GG~TGC  CA~CCAAT  CGCAATGACAATTCCAGCAGGT  TTGGGAAATACATGGATATCAACTTT  °ACT  TC 
R  V  K  ML  LK  $  14  CV  LEAF  GNAKT  NRN  D  N  $  S  RF  GK  YMD  I  F  D  F  172 
721  AAGGGAGACCCCATT  GGGGGACATATTA ATAACTAC TTGCT  GOA~GTcTC  GTGTAATT GT  GCAACAGCCCGGAGAAcGAAGc  TTC  CATTCTTTcTAT~AGC TACT  TCAG~'GAGGTTC C 
K  G  D  I  G  G  R  I  N  N  Y  L  L  E  K  S  R  V  V  O  O  G  E  R  S  F  H  S  F  Y  0  L  L  G  G  212 
841  G~CAGATGCTGCATTCTCTACAT  CTG,  CAC~TCACT  CTCAT  CC  TACAACTACATCCGTGTGGGGGCACAACTGAAGTCTTCCATCAATGATGC  TGCAGAGTTCAAAGTTGTAGCTGAT 
E  Q  M  L  H  S  L  H  L  O  K  $  L  $  $  Y  N  Y  I  V  G  A  O  L  K  $  S  I  N  D  A  A  F  K  V  A  D  252 
961  GCCATGAAAGTAATTGGATT  CAAAC  CTGA~GAGATT CAAACAGTGTATAAAATTCT  GGCTGCTATT CTTCAC  TTGGGAAATTTAAAATTTATAGTAGATGGTGACACGCCAC  TTATTGAG 
A  M  K  V  I  G  F  K  P  E  I  0  T  V  Y  K  I  L  A  I  L  H  L  G  N  L  K  F  I  V  D  D  T  LIE  292 
10BI  AATGGCAAAGTTGTATCTGTCATAGCAGAATTGC  TCTCAACCAAGGCAGACAT~GTGGAGA^AGCCCTGCTTTAC  CGGACGGTGGCCACAGGCCGTGACATCATTGACAAACAGCACAC  G 
N  G  K  V  V  S  V  I  A  LLS  T  KADMVEKAL  LYRTVAT  GRD  I  D  Q  R  T  332 
1201  GAACA~GAGGCTAGCTACGGCAGAGA~GCCTTT  GCCAA~GCAATATAT  GAGCGCC  TC  TTT  TGT  TGGATT  GTTACTC  GCATCAATOACATCATCGA~GTCAAGAACTACGACACCACAGTA 
E  Q  E  A  $  Y  G  R  D  A  F  A  K  A  I  Y  R  L  F  C  W  I  V  T  R  N  D  I  E  V  N  Y  T  T  V  372 
1321  CATGC~CACAGTTATT  GGCGTCTTGGATAT CTATGGC  TTTGAAATCT TT  GACAACAACAGC TT  CGAGCAGTT CTGCATTAACTACTGCAAT  GAGAAGCTGCAGCAGCTGTTCATT 
M  G  K  N  T  V  G  V  L  D  I  Y  G  F  E  F  D  N  N  S  F  E  O  F  C  I  N  Y  C  N  E  L  0  L  F  I  412 
1441  CAGCTGGTGCTGAAGCAGGA~CAAGAGGAGTACCAGC  GGGAAGGAATCCCCTGGA~CACATTGATTACTT  CAACAAC  CAGATCATTGTGGACCTCGTGGAGCAGCAGCACAAAGGCAT  C 
(~  L  V  L  K  0  0  E  E  Y  0  R  E  G  I  W  K  H  I  D  Y  F  N  N  O  I  I  V  D  L  V  (~  O  H  K  G  I  452 
1561  ATTGC.~TC CTGGATGAC GCGTGTATGAATGTTGGCAAAGTCAC  TGATGG~TGTTCCT  CGAGGC  CCTTAACAGTAAATTGGGCAAACATGGTCATTTTTCCAGCCGAAAGACCTGTGCC 
I  A  I  L  D  D  C  M  N  V  G  K  V  T  D  M  F  L  E  A  L  N  S  K  G  K  G  H  F  S  R  K  T  C  A  492 
1681  TCAGACA~TCCTGGAGTTTGATCGGGACTTTCGAATCCGGCATTAT  GCAGGTGATGTCGTGTATT  C  TGT  CATC  GGTTT  CATT  GACAA~CAAACATACTTTATTTCA  %GACTTCAAG 
S  D  K  I  L  E  D  R  D  F  R  I  R  R  Y  A  G  D  V  V  Y  S  V  I  G  I  D  N  K  D  T  L  F  Q  D  F  K  532 
1801  CGCCT  CATGTATAACAGCTCAAATCC  TGTGC  TGAAGAACATGT GGCCGGAACGGAAAC  TGAGCATTACAGAGGT GACCAAGAGGCCT CTGACC  GCCGCCAC CCTGTTTAAGAATTCCATG 
R  L  M  Y  N  S  N  P  V  L  K  N  M  W  P  R  K  L  S  I  T  E  V  T  R  P  T  A  A  T  L  F  K  N  S  M  572 
1921  ATTGCTTTAGTAGACAACCTT  G~TTCAAAGGAGCCATACTATGTACGTTGCATCA~CCCAACGACAAGAAGTCCCCACAGATTTTTGAT  GATGAGCGTGGC CGCCATCAGGTAGAATAC 
I  A  L  V  D  N  L  A  $  K  E  P  Y  V  R  I  K  P  N  D  K  K  S  P  I  F  D  D  E  R  G  R  H  Q  V  E  Y  612 
2041  CTGGGACTC CTGGAAAAT GT  GAGAGTGC GC  CGGGCAGGGTTTGCC  TTCCGCCAGACCTAT  GAGAAGT  TT  CTTCACAGATACAAGAT  GATC  TCT  GAGTTCAC CTGGCCTAACCACGAC CTT 
LGLLENVRVRRAGrAFR~TYEKFLHR  K  M  I  S  E  F  T  W  P  N  H  D  L  652 
X 
2161  CCT  TC^C,  ACAAGGAGGCTGT CAAGAAACTCATAGAGCGAT  GTGGCT  TT  CAGGATGACGTAGC ^TAT  GGGAAGAC C  KA^AT  TTTCATTCG~ACACC CCGTACGC  T  GTT  CACT  TT~GAAGAA 
p  $DKEAVKKL  I  ERCGFQDDVAYGKTK  F  I  R  T  P  R  T  L  F  T  L  E  E  692 
2281  CTCCGCGC CCAGATGCTCGTCAGGGTTGTCCTCTTCCTACAA^AGGTGTGGCGTGGCAC  CC  TGGCCCGCATGCGGTACAAGAGGACCAAGGCAGCTCTGACAATAAT  CAGGTACTACC GG 
LRAQMLVRVVLF  LOKVWR  G  T  LARMRY  R  T  A  A  L  T  I  I  1~  Y  Y  R  732 
2401  CGCTATAAAGTGAAGTCGTACAT¢CACGAGGTAGCCAGGCGATTC°ACGGGGTCAAGAACAT  GAGAGACTACGGGAAGCA¢  GTGAAGT  GGCCAACCCCACCCAAAGTCCTGCGGCGTT  TT 
R  y  K  V  K  S  Y  I  H  E  V  A  R  F  H  G  V  K  N  M  R  D  Y  G  K  V  K  W  P  T  P  P  K  V  L  R  R  F  772 
x. 
2521  GAGGAGGCCCTGCAGTC  GATTTTTAATAC,  ATGGAGAGCATCCCAACTCATCAAGACCATACC  TGCATCA~ACCTTCCC CAGGTCAGGGCAAAGGTTGCAGCCATGGAGATGTTGA~GGT 
E  E  A  L  Q  S  F  N  R  W  R  A  S  Q  L  K  T  I  P  A  S  D  L  P  V  R  A  K  V  A  A  M  E  M  L  K  G  812 
X  x 
2641  CAAAGGGCAGACCTTGGGCT  CCAGAGGGCCTGGGAAGGCAACTATC  TTGCTTCAAAGCCAGATACACCTCAGACCTCGGGCACTTTCGTCCCAGT  TGCTAAT  GAGCTGAAACGCAAGGAC 
O  R  A  L  r-  L  Q  R  A  W  E  G  N  Y  L  A  s  K  P  D  T  P  O  T  5  T  F  V  P  V  A  N  E  L  K  R  K  D  852 
2761  AAATATAT GAATGTTCTC TTTT  CCTGT  CATGT  CC  GAAAG~TGAATCGAT  TTAGTAAGGTAGAAGACCGAGCAATT  TTTGTCACTGACC GTCACCTGTATAAAATGGACC  C  CACTAAGCAG 
K  Y  M  N  V  L  S  C  H  V  R  K  V  N  R  S  K  V  E  D  R  A  I  F  T  D  R  .  L  Y  K  M  D  P  T  K  Q  '92 
2881  TACAAGGTGAT G~GAt'CAT CC  CACTGTACAATTTGACT~GCC  TGAGTGTGTCCAATGGA~GGACCAGCT  TGTAGTGTT CCAcACAAA~GACAACAAAGACCTCATC~TCTGCCTC  TTC 
Y  K  V  K  T  p  L  Y  N  L  T  G  L  S  V  S  N  G  K  D  Q  L  V  V  R  T  K  D  N  K  D  L  I  V  C  L  932 
3001  AGCAAACAGC CGACC  CAT  GAGAGC  CGGAT  TGGAGAACTTGTTGGAGTCCTGGTGAATCATTTCAAGAGTGAGAAGCGCCACCTTCAAGTGAAC  GTCACCAACC CGGTGCAGT GCAGCCT  G 
S  K  Q  T  H  E  S  R  G  E  L  V  G  V  L  V  N  F  K  S  E  K  R  H  L  Q  V  N  V  T  N  P  V  0  C  S  972 
3121  CATGGGAAGAAATGCAC  CGTATCC  GTGGAGACCCGGCT TAACCAGCCACAGCC  TGACT  TCACCAAGAA¢ CGCTCCGGCTTCATCCTCAGTGTGCCCGGGAATTCmACT  GCTGCACACCGGA 
MGKKCTVSVETRLNOPQP  DF  TKNRSGF  I  LSVP  GN-  1006 
3241  GGCCT  GGCCCAGGGGAGCAAGAG  CCT  GGGCC  TGGCACACAGCAGGCCAGGTC  CT  CGCCTCGCCATC CCCACATCTGTTC CAC  CTC  GCTCAACATCC CAGGAGCTCGGCTAATC  GCTGTTT 
3721  GGCCCTGCT TT  °TGACCCCTACC TGATGCCTT CCACAACAT 
/qE.~ 2. Nuc|~d¢  and d~duccd amino acid  s~quenc~ of  myr 4 eDNA. Sta~  c  o  don (nt  206-207)and stop  c  o  don (nt  3223-3225) ar~ 
indica~ in  bold Ie~rs. The nuc|~otide  s~qucnc~ of  the  ini{~d  PCR fTagment is  underl~. P~p~de s~quenc°s obtained  from pur~d 
myr 4 by VS-protease digestion and subsequent direct amino acid sequencing are underlined. X's denote nns~signed amino acid residues. 
The peptide sequence in bold type represents the amino acid sequence reco~,niz~l by the polyclonal antiserum G-371. The nucleofide se- 
quence data are accessible through EMBL, GenBank, and DDB,I nucleotide sequence databases under the accession number X71997. 5.3 
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Figure 3.  Unrooted phylogenetic tree of myosin I head domains. 
This tree was constructed using the CLUSTAL V program (31). 
The horizontal branch lengths are in units of percent sequence 
divergence (indicated above each line). The sequence divergence 
between any pair of sequences is equal to the sum of the horizontal 
branch lengths connecting the two sequences. Bootstrapping  values 
for each node are given in percent; these values indicate the number 
of  times out of 10,000 data resampling trials that the sequences be- 
low a given node were found to cluster together. Dm MI, D. mela- 
nogastermyosinI  (Morgan, N. S., D. M. Skovronsky,  S. Artavanis- 
Tsakonas, and M. Mooseker);  myr  2, rat myosin  I (accession  number 
X74800); Bt MIB, bovine myosin I]3 (accession number Z22852); 
myr 1, rat myosin I (53); Mm Ml~t, mouse (mus musculus) myosin 
Ict (56); Bt BBM, bovine brush border myosin I (32); Gg BBM, 
chicken brush border myosin I (24); Dd MIE, D. discoideum my- 
osin IE (60); Dd MIA, D. discoideum myosin IA (59); Ac MIC, A. 
castellanii myosin  IC (35); Dd MID, D. discoideum myosin-lD  (34); 
Ac MIB, A. castellanii myosin IB (37); Dd MIB, D. discoideum my- 
osin IB (36); myr 3, rat myosin I (accession number X74815); Gg 
BBMIB, chicken brush border myosin I13 (Knight, A., and J. Ken- 
drick-Jones, accession number X70400). 
four amino acid residues, namely residues 323,  353,  364, 
and 550. 
The putative light chain binding domain of myr 4 (amino 
acids 700-762) contained two consecutive IQ motifs that are 
predicted to serve as ealmodulin/light chain binding sites 
(see Fig. 6 and below). These two IQ motifs were followed 
by an additional 19 mostly basic and hydrophobic residues. 
Overlapping with the IQ motifs, we noted four BBXB motifs 
(B, basic residue; X, any residue), each spaced by exactly 
nine amino acid residues. The carboxy-terminal border of 
the regulatory domain was defined by a cluster of proline 
residues (PTPP,  amino acids 763-766). 
The tail domain of myr 4 (amino acid 763-1006)  is en- 
riched in basic (pI =  10.77) and hydrophobic (31.8%) amino 
acid residues as is typical for the tail domains of other myo- 
sin I molecules. However, pairwise tail sequence compari- 
sons (starting after the last IQ motif) with other vertebrate 
myosin Fs revealed a  sequence  identity of only 20--27% 
(43--49 % similarity). Repeatedly shuffling the myr 4 tail se- 
quence yielded values of 20%  identity (40%  similarity), 
demonstrating the limited sequence homology of the myr 4 
tall with other myosin I tails. In comparison, chicken brush 
border myosin I, bovine brush border myosin I, and myr 1 
exhibited 42-50% sequence identity (64-72.5% similarity). 
These differences in tail amino acid sequence conservation 
between myr 4 and the other vertebrate myosin Is, as well 
as the disparity between tail and head domain sequence con- 
servation, are illustrated in Fig. 4. Examination of such tail 
amino acid sequence comparisons between currently known 
myosin I molecules revealed, however, that they share a se- 
quence motif that was present in all of them, and hence rep- 
resented a myosin I tail homology motif (Fig. 5). This motif 
was found only in the tail domains of class I myosin mole- 
cules, but not in tail domains of myosins belonging to other 
classes. The motif was characterized by three short blocks 
of conserved residues (26--40  amino acids in length) that 
were or were not interrupted by insertions specific for myo- 
sin I subclasses as defined already by comparison of  head se- 
quences (see Fig. 3). Myr 4 and D.  discoideum myosin IE 
exhibited an insertion between the first and second block of 
conserved residues; the amoeboid myosin I's exhibited an in- 
sertion between the second and third block of conserved 
residues, whereas the brush border type myosin I's exhibited 
no insertion (Fig. 5). The degree of conservation in the ho- 
mologous parts also fitted well with the classification de- 
duced from head sequence alignments. Most highly con- 
served  was  the third block of residues  encompassing 26 
amino acids. This part of the motif  is characterized by alter- 
nating hydrophobic and hydrophilic residues and two con- 
served charged residues, an aspartic acid and a histidine resi- 
due, respectively. 
Analysis of Calmodulin Binding by myr 4 
Several vertebrate myosin-I molecules have been demon- 
strated to bind the Ca2+-binding protein calmodulin (CAM) 
(4, 25, 53). We therefore analyzed whether myr 4 exhibited 
any CAM-binding activity. CaM was detected in preparations 
of affinity-purified myr 4 by immunoblotting but not in prep- 
arations purified with control antibodies (data not shown), 
suggesting that indeed CAM is associated with myr 4. Evi- 
dence in support of this notion was also provided by immu- 
noprecipitation  experiments  from  35S-labeled  C6-glioma 
cells.  A  band comigrating with authentic CAM was  spe- 
cifically immunoprecipitated by myr 4 antibodies (data not 
shown). In addition, a band with the appropriate molecular 
weight for CAM was consistently observed in fractions en- 
riched for myr 4 (see Fig. 1). Furthermore, myr 4 was able 
to bind CaM both in the presence and absence of free Ca  2÷ 
in CaM overlay assays (data not shown). 
To identify the CaM binding sequences in myr 4, we con- 
strutted a  series of fusion proteins encompassing various 
portions of the two IQ motifs present in the putative light 
chain binding domain of myr 4 (Fig. 6 D). It had previously 
been postulated that IQ motifs represent calmodulin/light 
chain-binding sites (6).  CaM overlay assays demonstrated 
that both myr 4 IQ motifs were able to bind CaM albeit under 
different free  Ca  2+  concentrations  (Fig.  6).  The  amino- 
terminal IQ motif (amino acids 700-721) bound CAM only 
weakly in the presence of free calcium but strongly in the ab- 
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son of myr 4  amino acid se- 
quence  with  other vertebrate 
myosin-I  sequences  and  the 
Dictyostelium  myosin  IE se- 
quence.  The amino acid  se- 
quences were compared using 
the  GCG  software  package 
with a stringency of 14 amino 
acids in a window of  25 amino 
acids.  The dot matrix repre- 
sentation  demonstrates  the 
high  level of conservation  in 
the head domains and the lack 
of conservation in the tail do- 
mains  with  exception  of the 
tail homology motif. Abbrevi- 
ations used for myosin I mole- 
cules are described  in Fig. 3. 
sence of free calcium ions. In contrast, the carboxy-terminal 
IQ motif (amino acids 722-743) bound calmodulin strongly 
in the presence of free calcium, but only weakly in the ab- 
sence  of free  calcium.  The  difference in  Ca2+-concentra  - 
tions required for optimal binding of CaM by the two IQ mo- 
tifs is unlikely to be an artifact of fusion protein construction 
or the gel overlay assay because binding was strictly depen- 
dent on the presence of the respective 22 amino acids. Fur- 
thermore, the fusion protein that contained both IQ motifs 
(amino acids 500-743)  bound  calmodulin both in the  ab- 
sence and presence of free calcium in a manner equivalent 
to  the  sum  of the  two  separate IQ  motifs.  These  results 
demonstrated that each of the two IQ motifs encoded a CaM- 
binding  site.  However, the two IQ motifs exhibited drasti- 
cally different  free  calcium ion  requirements  for optimal 
binding of CaM. 
Remarkably, a myr 4  tail fusion protein encoding amino 
acids 776-1,006  also exhibited CaM-binding activity (Fig. 
Bilder et al. Mammalian Myosin 1  381 Figure 5. Identification of a myosin I tail homology motif present in all currently available myosin I tail sequences. An alignment of the 
amino acid sequences is shown. Myr 4, amino acids 806-920; myr lc, amino acids 886-1050 (53); myr 2, amino acids 841-945 (Ruppert, 
C., I. Gedel, J. Reinhard, and M. B~tler, accession number X74800); A. castellanii myosin-IB (Ac MIB) amino acids 701-821 (37); A. 
castellanii myosin-IC (Ac MIC), amino acids 696-818 (35); D. discoideum myosin-IA (Dd MIA), amino acids 771-890 (59); D. discoideum 
myosin-IB  (Dd MIB), amino acids 721-860 (36); D. discoideum myosin-ID (Dd MID), amino acids 720-840 (34); D. discoideum myosin-IE 
(Dd MIE), amino acids 801-912 (60); bovine brush border myosin I (Bt BBM), amino acids 850-956 (32); bovine myosin-IB (Bt MIB), 
amino acids 842-945 (Reizes, O., C. Li, C. Sudhof, and J. P. Albanesi, accession number Z22852); chicken brush border myosin I (Gg 
BBM), amino acids 808-914 (24); chicken brush border myosin-IB (Gg BBMIB), amino acids 720-835 (Knight, A., and J. Kendrick-Jones, 
accession number X70400).  Shaded residues denote identical or similar amino acids. 
7). The CaM-binding activity of this construct was depen- 
dent on calcium (data not shown). To define the tail binding 
region, we expressed a series of myr 4 tail fragments fused 
to maltose-binding protein (Fig. 7). CaM binding could be 
achieved with fragments containing amino acids 776-874. 
Fragments including only part of this region either did not 
bind CaM at all or showed only marginal CaM binding activ- 
ity.  Even stronger CaM  binding  was  observed with frag- 
ments starting at amino acid 776 and ending between amino 
acids 896 and 1006, but not with a fragment encoding amino 
acids 743-898.  These results suggested that the myr 4 tall 
CaM-binding activity was not solely dependent on a  short 
stretch of amino acid sequence, as demonstrated for the IQ 
motifs. 
Distribution of myr 4 
Antisera were raised against a bacterially expressed myr 4 
fragment  (amino  acids  513-1,006)  tagged  with  6xHis 
residues (Tfi 14) and a synthetic myr 4 peptide (Tii 12,  13), 
and affinity purified over a bacterially expressed myr 4 tail 
fragment (amino acids 776-1,006) fused to maltose-binding 
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0.I  mlVl  3mM 
1  500  I  I  699  - 
2  500  I  f'-I  721  +  +++ 
3  500  I  I"1--1  743  +++  +++ 
4  722  ~  777  +++  + 
5  743 k---I  777  - 
I::  IQ  motifs 
neuromodulin  33 L%ATK IOASFROH  ITI~,KKLKGE 55 
myr 4  I  7o0 RVVLFLQKVWI~GTLARMRYKRT  721 
myr 4 II  722 I~KALT.rIRYYIe,_RYKVKSYIHEV743 
Figure 6.  The two IQ motifs present in myr 4 bind calmodulin in 
a  differentially Ca2+-sensitive  manner.  Coomassie brilliant blue- 
stained SDS-gel (,4) and autoradiographs of  identical gels incubated 
with I~I-calmodulin in the presence (0.1 mM Ca  2+) (B) or absence 
of free calcium ions (3 mM EGTA) (C) axe shown. Fusion proteins 
of maitose-binding protein with myr 4 fragments spanning variable 
regions of  the regulatory domain were expressed in E. coll. Whole- 
cell lysates were separated by SDS-PAGE. Expressed myr 4 frag- 
ments separated on lanes 1-5 are schematically depicted in (D) and 
numbered accordingly. IQ motifs (boxes) are indicated. Lane M in- 
eludes  the  following  markers:  myosin  heavy  chain,  205  kD; 
B-galactosidase, 116 kD; phosphorylase b, 97.4 kD; bovine serum 
albumin, 66 kD; ovalbumin, 45 kD; and carbonic anhydrase,  29 kD. 
Calrnodulin-binding results obtained with the various myr 4 frag- 
ments (B and C) are schematically summarized in (D). No binding 
is indicated by (-), and increasing strength of binding is indicated 
by numbers of (+).  (E) The amino acid sequences of the two myr 
4  IQ motifs are aligned with each other and the IQ motif of the 
calmodulin binding protein neuromodulin (5). Residues conserved 
between neuromodulin and myr 4  are printed in bold type. 
protein.  These antibodies recognized specifically the identi- 
cal ll0-kD protein that we had identified as myr 4  with our 
myosin  I  consensus  antibody.  Tissue  distribution  studies 
with these myr 4--specific antibodies demonstrated that myr 
4 was most prominently expressed in the adult brainstem and 
spinal cord, and at slightly lower levels in cortex and cerebel- 
lum (Fig.  8).  Reduced  levels of myr 4  as compared to the 
four  brain  regions  were  detected  in  lung,  kidney,  spleen, 
liver, testis, and heart muscle. Barely detectable levels were 
observed in embryonic brain tissue. 
Figure  7.  Ca2+-dependent  calmodulin binding of myr 4  tail con- 
structs.  Various  myr 4 tail constructs danes 1-14), schematically 
depicted in (C), were expressed in E. coil and separated on SDS- 
PAGE. Coomassie blue-stained SDS-gel (,4) and autoradiograph of 
an identical gel incubated with l~I-caimodulin in the presence (0.1 
mM) of free calcium ions (B) are shown.  Size standard markers 
(M) inA are identical to those in Fig. 5. Calmodulin binding of the 
various myr 4 tail constructs is summarized in (C). The shaded area 
denotes the region involved in calmodulin binding. No ealmodulin 
binding is indicated by (-), and the increasing strength of binding 
is indicated by numbers of (+). 
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from different tissues and brain regions were separated on SDS- 
PAGE and immunoblotted with the affinity-purified  myr 4 antibody 
Tfi 12, followed  by a secondary antibody coupled to alkaline phos- 
phatase. The respective position of myr 4 is indicated. Molecular 
mass standards in kilodaltons are shown on the right. Tissues are 
indicated on top of each lane, with El9 denoting embryonic day 19 
rat brain. 
Several cell lines were screened for myr 4 expression by 
immunoblotting. As shown in Fig. 9, myr 4 was detected in 
C6, PC12, NMU, MDCK, HepG2, NIH3T3, and COS cells. 
Myr 4  was barely detectable in AtT20,  IC-21, and P388DI 
ceils,  and  not  detectable in  Neuro-2A  cells.  These  data 
demonstrated that myr 4 is expressed in many tissues and cell 
lines, albeit at varying levels. Similar results were obtained 
by Northern blot analysis, which demonstrated that myr 4 
mRNA  is  also  relatively  abundant  in  intestine  (data  not 
shown). 
Expression of myr 4 during Rat Forebraln Development 
We investigated the expression of myr 4 during rat forebrain 
development. As shown in Fig. 10, expression of myr 4 pro- 
rein was barely detectable at embryonic and early postnatal 
days, markedly increased during postnatal weeks 2-3,  and 
remained at high levels until adulthood. This result demon- 
strated that myr 4 expression in brain tissue is developmen- 
tally regulated. 
Immunofluorescence Localization of myr 4 in Brain 
Sections and in Cultured Cells 
We determined the localization of myr 4  in two regions of 
the adult rat brain (Fig. 11). The cell bodies and apical den- 
drites of a  subpopulation of neurons were prominently la- 
beled in the cortex and thalamus. In the cortex, a subpopula- 
tion of pyramidal cells in layers 5 and 6 exhibited punctate 
staining (Fig. 11 A) reminiscent of an organellar association. 
A subpopulation of neuronal cell bodies and apical dendrites 
was also stained in the thalamus (Fig. 11 B). Based on their 
morphology, these cells are likely to represent projection 
Figure 9. Expression of myr 4 protein in various cell lines. Equal 
amounts of protein from various cell lines, rat brainstem, and em- 
bryonic day 19 rat brain tissue were separated on SDS-PAGE  and 
immunoblotted with ~  14 (A) or Tii 12 (B) antibody. Cell lines 
or brain tissues are indicated on top of  each lane. Molecular weight 
markers are given in kilodaltuns. Note the specificity of TO 12 and 
Tfi 14 antibodies in the C6-cell line. 
neurons. In both brain regions, a weaker general punctate 
labeling that was not easily attributable to particular struc- 
tures was also evident. A similar punctate myr 4 immunore- 
activity  was observed  in subpopulations of neurons  in the 
brainstem (data  not shown). 
In the rat C6 glioma cell homogenate, the antibodies Tfi 
12 and Tfi 14 reacted monospecifically with myr 4 (Fig. 9). 
This cell line was therefore used to localize myr 4 by indirect 
immtmofluorescence (Fig. 12). As in the neurons stained in 
sire, a punctate staining pattern throughout the C6 cells was 
observed (Fig. 12). The punctae sometimes appeared to fine 
up along invisible tracks. However, double immunofluores- 
cence staining with phallacidin failed to demonstrate an ob- 
vious colocalization of myr 4-positive punctae with aetin 
filaments (Fig. 12, B and C). The observed ptmctate staining 
pattern was reminiscent of an organellar localization. How- 
ever,  double  immunofluorescence studies  with  organellar 
markers failed so far to identify a  candidate organelle. In 
particular, no apparent colocaliTation with o~-adaptin or eav- 
eolin was observed (data not shown). 
Discussion 
Myr 4 Defines a New Subclass of  Myosin I 
Using  our previously described myosin-I consensus  anti- 
body (53), we have identified myr 4, a novel mammalian my- 
osin I. The characterization ofmyr 4 as a class I myosin mol- 
ecule was  based  on biochemical and  sequence data.  We 
demonstrated that it is extracted from tissue homogenates by 
MgATP, that it binds in a nucleotide-dependent manner to 
F-actin, and that it binds calmodulin. Sequence data revealed 
that myr 4  consisted of a  typical myosin head domain,  a 
regulatory light chain-binding domain, and a tall domain. 
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Equal amounts of protein from embryonic day 17 (E/7), postnatal 
days 2-51  (P2-P51) and adult rat forebrain tissue homogenates 
were separated on SDS-PAGE and transferred to nitrocellulose. 
The nitrocellulose was incubated with antibody Tii 12 followed by 
a secondary antibody coupled to alkaline phosphatase. 
Comparison of the myr 4 head domain amino acid sequence 
with the amino acid sequences of  other myosin head domains 
demonstrated that myr 4 is a class I myosin (for nomencla- 
ture see reference 7). However, myr 4 could not be grouped 
unequivocally with any of the known myosin I subclasses. It 
was  not  significantly more homologous to  the vertebrate 
brush border type myosin I subclass, which includes myr 1, 
the only other identified myosin I from rat, than to myosin 
IA and IE from D. discoideum.  Myr 4 may therefore repre- 
sent a member of a novel myosin I subclass.  This notion is 
supported by the analysis of several unpublished myosin I 
amino acid sequences (Fig. 3) and the lack of extensive se- 
quence homology between myr 4 and other myosin I tail do- 
main sequences, except for the myosin I tail homology motif. 
Identification of a Myosin I Tail Homology Motif 
Analysis of divergent myosin I  tail domain sequences re- 
vealed a common amino acid motif characteristic of myosin 
I tails. This motif  was identified in all presently available my- 
osin I tail sequences, but not in tail sequences of other myo- 
sins, and it is therefore diagnostic of myosin I tail domains. 
The tail homology motif forms part of the tail homology 1 
region previously defined by comparison of protozoan myo- 
sins I (34). It consists of  three regions with particular conser- 
vation that may be  separated by short myosin I  subclass 
(defined by head  sequence comparisons)  specific inserts. 
The high degree of conservation implies that this motif is of 
functional significance. The only common function ascribed 
to myosin I tail domains is their capability to interact with 
membranes. A phospholipid-binding site has been localized 
to a tail fragment (amino acids 701-888) of Acanthamoeba 
myosin IC that contains most of the tail homology motif 
(amino acids 696-818) (17).  Further experiments will have 
to address whether the tail homology motif plays a role in 
membrane binding or any other as yet unidentified function 
common to myosin Is. 
Differences between myr 4 and myr 1 
Unlike myr 1, which is closely related to brush border myo- 
sin I, myr 4 defines a new subclass of myosins I. It represents 
Figure 11. Immunoloealization of myr 4 in two brain regions. Coronal cryosections of rat cortex (A) and thalamus (B) were labeled by 
indirect immunofluorescence with antibodies to myr 4 (A, Tii 12, and B, Tfi 14) using a secondary antibody coupled to Cy3. Prominent 
punctate immunoreaetivity is seen in pyramidal ceil bodies and their apical dendrites of cortical layers 5 and 6, as well as in relay neurons 
in the thalamus. Inset in (,4) shows a confocal image to demonstrate punctate staining. Bar, 50 #m. 
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related to brush border myosin I. As opposed to myr 1 that 
exists in three alternatively spliced forms, we have so far de- 
tected no evidence for alternatively spliced forms of myr 4. 
Myr 4 and myr 1 differed in their extraction behavior from 
tissues. Myr 4 was more difficult to solubilize than myr 1. 
Upon homogenization  of  brain tissue, virtually  all myr 4 pro- 
rein, but only '~50% of myr 1, was recovered in the particu- 
late fraction. The nucleotide ATP readily released most of 
the particulate myr 1, but myr 4 was released only in con- 
junction with high ionic  strength.  Detergent and elevated 
pH values aided in the release of myr 4  (Kieferie, S., and 
M. Bahler, unpublished observations). The tail domain of 
myr 4 did not contain sequences present in the tail domains 
of amoeboid myosin I  molecules,  which are  involved in 
nucleotide-independent actin binding (17, 43).  The harsh 
treatments needed for myr 4 solubilization are therefore un- 
likely to result from nucleotide-independent actin binding. 
Furthermore, partially purified myr 4 was readily released 
from F-actin by MgATP. It will therefore be of interest to de- 
termine with which molecule(s) myr 4 is associated. 
Expression levels of myr 4 and myr la exhibited a strik- 
ingly converse regulation during brain development. Myr 4 
protein levels increased during postnatal rat brain develop- 
ment and were highest in the adult brain, whereas myr la lev- 
els were high in embryonic brain tissue and decreased during 
postnatal development. Currently, we do not know whether 
myr 4 and myr la are expressed in the same or different cells. 
Myr 1 was reported to be expressed in neurons (56).  We 
demonstrated in this report that myr 4 is expressed in sub- 
populations of neurons in the adult rat brain. Myr 4 expres- 
sion might be induced by synaptogenesis or gliogenesis be- 
cause  both  processes  in  rats  mostly  take  place  during 
postnatal development. So far, we have not been able to re- 
late any functional differences between neurons to myr 4 ex- 
pression. 
Both myr 4 and myr 1 were found to be expressed in all 
tested tissues. However, the relative expression levels in the 
various tissues differed for the two proteins. In tissues from 
adult rats, myr 1 was most prominently expressed in lung, 
whereas myr 4  was most prominently expressed in brain. 
These results together with the different  developmental regu- 
lation suggest that myr 4 and myr 1 play general but noniden- 
tical roles. 
Differential Ca  z÷  Sensitivity of  Calmodulin Binding by 
IQ Mo#  
Myosin molecules contain various numbers of light chains. 
It was recently suggested by Cheney and Moosek~r (6) that 
a motif, called the IQ motif, found in the regulatory domains 
of myosins,  provides  a  binding  site  for  proteins  of the 
calmodulin/EF-hand superfamily, and that these sites gener- 
ally retain their binding activity, even in the absence of cal- 
cium. Two consecutive imperfect repeats of 22 amino acids 
Figure 12. Immunolocalization  ofmyr 4 in rat glioma C6 cells. C6 
cells were labeled by indirect immunofluorescence with antibody 
Tfi 14 (A) using a secondary antibody coupled to Cy3, with anti- 
body ~  12 (B) using a secondary antibody coupled to rhodamine, 
or  with  fluoresceine-phallacidin (C), respectively. Double im- 
munofluorescence  labeling for myr 4 and F-actin is shown in B and 
C. Bar, 10/~m. 
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domain of myr 4. Preparations of myr 4 purified from rat 
brain  contained  cahnodulin.  This  finding  indicated  that 
calmodulin is complexed with myr 4. Because of the small 
amounts of purified myr 4  available, no stoichiometry of 
calmodulin binding could be determined. Direct binding of 
calmodulin to myr 4 was demonstrated in a ~25I-calmodulin 
overlay assay. By producing several constructs that encoded 
either a single IQ motif, both IQ motifs, or no IQ motif, we 
were able to demonstrate that each of the two IQ motifs rep- 
resented  a  calmodulln  binding  site.  The  two  IQ  motifs 
differed in their dependency on calcium for calmodulin bind- 
ing.  The  NH2  terminal IQ  motif bound calmodulin well 
only in the absence of free calcium, whereas the COOH- 
terminal IQ motif-bound calmodulin well only in the pres- 
ence of free calcium. No apparent cooperativity between 
these two calmodulin binding sites was detected in the con- 
struct encoding both IQ motifs. These results demonstrate, 
for the first time, that IQ motifs can exhibit drastically differ- 
ent dependencies on calcium for calmodulin binding, and 
that an IQ motif can bind calmodulin in a Ca2+-dependent 
manner. It has been noted for chicken brush border myosin 
I that micromolar concentrations of calcium cause a partial 
release of bound calmodulin (9,  10, 58).  The affinities for 
calmodulin binding depending on free Ca  2+ concentrations 
remain to be determined for the two myr 4 IQ motifs. This 
information will be needed to speculate on the numbers of 
calmodulin molecules associated with myr 4 under physio- 
logical conditions. In addition, structural data will be needed 
to determine which residues in IQ motifs confer differential 
Ca  2+ sensitivity for calmodulin binding. In the motif IQX- 
XXRGXXXR,  the glutamine and glycine residues are ex- 
changed for an isoleucine and an arginine, respectively, in 
the carboxy-terminal myr 4 IQ motif. The amino-terminal 
myr 4 IQ motif and the neuromodulin IQ motif, which both 
bind calmodulin stronger in the absence of Ca  2+, conform to 
the consensus sequence (reference 5 and this report). From 
the presented calmodulin-binding results, it seems likely that 
myr 4 activity will be regulated by Ca2÷/calmodulin. 
Upon analysis of calmodulin binding by the myr 4 regula- 
tory domain, we noticed that a construct encoding the tail 
domain  exhibited  calcium-dependent  calmodulin-binding 
activity in  t25I-calmodulin gel overlays. A  variety of con- 
structs designed to identify the tall calmodulin binding se- 
quence demonstrated that amino acids 776-874 were neces- 
sary for calmodulin binding.  This region is considerably 
larger than the calmodulin-binding regions of known cal- 
modulin-binding proteins  (e.g.,  the  IQ  motifs).  Further- 
more,  the relative amounts of calmodulin bound to con- 
structs  with different NH2  termini containing the critical 
region were variable. Recently, the phospholipid/membrane 
binding domain of the plasma membrane Ca  2+ pump was 
shown to bind calmodulin (21). Several members of the EF- 
hand superfamily, including calmodulin, are known to bind 
membranes or hydrophobic supports in the presence of cal- 
cium (19, 63). Therefore, it seems possible that in vivo, this 
region  represents  a  phospholipid/membrane binding  site 
rather than a  calmodulin-binding site.  This region (amino 
acids 776-874) partially overlaps with the myosin I tail ho- 
mology motif (amino acids 805-920),  which represents a 
candidate phospholipid binding site. Future experiments will 
have to address this possibility. 
Localization of myr 4 
To understand the possible roles of myosin I molecules in 
cellular trafficking, one needs to determine their subcellular 
distributions. Examination of the subcellular localization of 
myr 4 revealed a punctate distribution. This punctate distri- 
bution was reminiscent of a membranous, organellar local- 
ization. Double immunofluorescence staining with F-actin 
demonstrated no apparent colocalization, indicating that un- 
der steady-state conditions myr 4 localization within cells is 
mainly determined via its tail domain rather than the actin- 
binding head domain. So far, we have been unable to deter- 
mine the organelle that myr 4 is associated with. Determina- 
tion of  the organellar membrane that myr 4 is associated with 
will require immunoelectron microscopy and identification 
of an organellar marker that colocalizes with myr 4.  Al- 
though we cannot conclusively rule out that myr 4 is not as- 
sociated with an organellar/vesicular membrane, myr 4 con- 
sistently fractionated on sucrose gradients with a density of 
1.14-1.16 g/cm  3,  the same density as,  e.g., plasma mem- 
brane (Kroschewski, R., R. Mtiller, and M. Bahler, unpub- 
lished observations). 
The localization of myr 4 contrasts with the localizations 
reported for other vertebrate myosin I molecules. Brush bor- 
der myosin I, a bovine myosin I purified from adrenal gland, 
and a 120-kD protein of Swiss 3T3 fibroblasts cross-reactive 
with an antibody raised against chicken brush border myosin 
I  were all found to be concentrated in actin-rich cortical 
regions (13, 18, 46, 61). These observations prompted specu- 
lations that the mentioned myosin rs are involved in motile 
events at the cell surface. However, all three proteins are pos- 
sibly also located on membraneous organelles. Some brush 
border myosin I was detected on vesicles (18),  a punctate 
perinuclear staining was observed in some cells for the bo- 
vine adrenal myosin I (61), and discrete, punctate spots were 
observed in the lamellae, as well as in the perinuclear region 
of Swiss 3T3 cells, with the antibody against chicken brush 
border myosin I  (13).  The respective myosin I  motor do- 
mains, responsible for actin binding, might therefore play 
different roles in determining the steady-state localizations. 
Alternatively, the observed differences in apparent colocali- 
zation with actin filaments might simply reflect associations 
with different membrane compartments. It remains to be de- 
termined whether  vertebrate  myosin I  molecules  are  in- 
volved in cell shape changes, membrane dynamics, or both. 
In conclusion, myr 4 represents a widely distributed myo- 
sin I that defines a new subclass of myosin I. All currently 
sequenced myosin I molecules contain a conserved motif in 
their tail domains.  Myr 4  exhibits three in vitro mapped 
cahnodulin-binding sites, whereby one IQ motif, contrary to 
previously characterized calmodulin binding by myosins, re- 
quired free Ca  2+ for optimal calmodulin binding activity. 
Myr 4 is likely to play a role in membrane traffic that is regu- 
lated by Ca2+/calmodulin. 
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